See more : Prodways Group SA (0RQB.L) Income Statement Analysis – Financial Results
Complete financial analysis of Ajanta Pharma Limited (AJANTPHARM.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ajanta Pharma Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Ponsse Oyj (PON1V.HE) Income Statement Analysis – Financial Results
- freee K.K. (4478.T) Income Statement Analysis – Financial Results
- Santa Fe Minerals Limited (SFM.AX) Income Statement Analysis – Financial Results
- Youngtek Electronics Corporation (6261.TWO) Income Statement Analysis – Financial Results
- JPMorgan European Growth & Income plc (JEGI.L) Income Statement Analysis – Financial Results
Ajanta Pharma Limited (AJANTPHARM.NS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.ajantapharma.com
About Ajanta Pharma Limited
Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets finished dosages. The company markets and serves various therapeutic segments, such as anti-biotic, anti-malarial, anti-diabetic, cardiology, gynecology, pediatric, respiratory and general health products, dermatology, ophthalmology, and pain management areas. It also provides multivitamins, antibiotics, eye drops, cough syrups, etc. The company serves in India, Africa, rest of Asia, the United States, and internationally. It supplies its products to government bodies, including armed forces, government hospitals, canteens, stores department, etc. The company was founded in 1973 and is headquartered in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 42.09B | 37.43B | 32.84B | 28.47B | 25.62B | 20.16B | 20.60B | 19.16B | 17.08B | 14.55B | 11.81B | 9.22B | 6.77B | 5.05B | 4.08B | 3.49B | 3.09B | 2.58B | 2.30B | 1.99B |
| Cost of Revenue | 11.15B | 10.50B | 8.87B | 6.82B | 6.90B | 4.24B | 4.72B | 4.71B | 4.50B | 3.87B | 3.60B | 3.12B | 2.30B | 1.73B | 1.46B | 1.27B | 1.40B | 1.40B | 1.22B | 1.03B |
| Gross Profit | 30.93B | 26.92B | 23.97B | 21.65B | 18.72B | 15.93B | 15.88B | 14.46B | 12.58B | 10.69B | 8.21B | 6.10B | 4.47B | 3.32B | 2.62B | 2.22B | 1.69B | 1.18B | 1.08B | 951.33M |
| Gross Profit Ratio | 73.50% | 71.93% | 73.00% | 76.03% | 73.06% | 79.00% | 77.10% | 75.44% | 73.65% | 73.44% | 69.52% | 66.17% | 66.05% | 65.75% | 64.30% | 63.63% | 54.69% | 45.72% | 46.91% | 47.91% |
| Research & Development | 2.08B | 2.37B | 2.04B | 1.39B | 1.64B | 1.76B | 1.86B | 1.50B | 1.06B | 700.70M | 590.40M | 412.90M | 0.00 | 248.84M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.30B | 710.70M | 545.90M | 384.00M | 283.10M | 208.40M | 300.40M | 263.20M | 214.20M | 159.30M | 133.60M | 116.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 2.53B | 2.27B | 2.98B | 2.38B | 3.04B | 2.41B | 2.27B | 2.08B | 1.92B | 1.93B | 1.61B | 1.34B | 0.00 | 0.00 | 487.56M | 0.00 | 0.00 | 0.00 | 198.45M | 200.53M |
| SG&A | 9.12B | 2.98B | 3.52B | 2.77B | 3.33B | 2.62B | 2.57B | 2.35B | 2.14B | 2.09B | 1.74B | 1.45B | 0.00 | 0.00 | 487.56M | 0.00 | 0.00 | 0.00 | 198.45M | 200.53M |
| Other Expenses | 0.00 | 986.40M | 152.90M | 56.00M | 68.70M | 11.50M | 5.10M | 39.70M | 7.00M | 2.90M | 8.90M | 3.00M | 3.32B | 2.33B | 1.56B | 1.69B | 1.24B | 862.11M | 623.68M | 554.71M |
| Operating Expenses | 11.20B | 20.40B | 15.86B | 12.72B | 12.61B | 10.90B | 9.81B | 7.78B | 7.15B | 6.15B | 4.96B | 4.20B | 3.32B | 2.58B | 2.05B | 1.69B | 1.24B | 862.11M | 822.13M | 755.24M |
| Cost & Expenses | 22.41B | 30.90B | 24.72B | 19.55B | 19.51B | 15.13B | 14.52B | 12.49B | 11.65B | 10.01B | 8.56B | 7.32B | 5.62B | 4.30B | 3.51B | 2.96B | 2.64B | 2.26B | 2.04B | 1.79B |
| Interest Income | 277.10M | 84.60M | 146.50M | 35.10M | 10.60M | 19.10M | 9.50M | 23.90M | 35.20M | 111.40M | 99.20M | 18.60M | 11.33M | 0.00 | 5.00M | 2.77M | 0.00 | 0.00 | 858.00K | 205.00K |
| Interest Expense | 72.10M | 58.40M | 102.00M | 82.70M | 119.10M | 11.60M | 4.10M | 12.40M | 25.00M | 36.90M | 65.10M | 133.90M | 241.33M | 178.21M | 201.60M | 235.52M | 161.44M | 123.77M | 120.49M | 101.46M |
| Depreciation & Amortization | 1.35B | 1.30B | 1.25B | 1.16B | 952.20M | 720.80M | 595.90M | 612.10M | 450.60M | 516.40M | 438.80M | 341.70M | 318.69M | 247.49M | 207.34M | 141.99M | 78.74M | 87.45M | 89.51M | 92.24M |
| EBITDA | 12.57B | 8.81B | 10.44B | 10.24B | 7.71B | 5.88B | 6.83B | 7.11B | 6.06B | 5.14B | 3.82B | 2.30B | 1.47B | 991.36M | 796.54M | 667.12M | 528.98M | 404.94M | 350.00M | 287.68M |
| EBITDA Ratio | 29.86% | 23.56% | 31.16% | 35.90% | 30.92% | 28.88% | 32.99% | 37.62% | 35.19% | 35.65% | 32.19% | 24.33% | 21.69% | 19.64% | 19.52% | 19.34% | 17.10% | 15.69% | 15.34% | 14.49% |
| Operating Income | 19.68B | 6.62B | 8.08B | 8.90B | 5.88B | 4.95B | 6.07B | 6.67B | 5.43B | 4.54B | 3.25B | 1.90B | 1.15B | 743.88M | 571.59M | 533.66M | 450.24M | 317.49M | 255.47M | 196.09M |
| Operating Income Ratio | 46.75% | 17.68% | 24.60% | 31.27% | 22.94% | 24.53% | 29.48% | 34.82% | 31.78% | 31.18% | 27.51% | 20.64% | 16.99% | 14.73% | 14.02% | 15.28% | 14.55% | 12.31% | 11.12% | 9.87% |
| Total Other Income/Expenses | -8.54B | 341.80M | -6.86B | 364.60M | 535.00M | -5.03B | -4.85B | 407.50M | 29.20M | -3.47B | -218.20M | -135.20M | -191.22M | -178.21M | -183.99M | -221.55M | -161.44M | -123.77M | -112.95M | -102.10M |
| Income Before Tax | 11.14B | 7.45B | 9.09B | 9.00B | 6.64B | 5.14B | 6.23B | 6.48B | 5.47B | 4.56B | 3.30B | 1.77B | 909.58M | 565.66M | 387.61M | 298.14M | 288.79M | 193.73M | 142.52M | 93.99M |
| Income Before Tax Ratio | 26.47% | 19.91% | 27.69% | 31.62% | 25.92% | 25.50% | 30.23% | 33.82% | 32.06% | 31.34% | 27.93% | 19.18% | 13.43% | 11.20% | 9.51% | 8.53% | 9.33% | 7.51% | 6.20% | 4.73% |
| Income Tax Expense | 2.98B | 1.57B | 1.97B | 2.46B | 1.96B | 1.27B | 1.54B | 1.41B | 1.46B | 1.46B | 959.70M | 646.80M | 136.93M | 58.54M | 47.57M | 43.83M | 68.50M | 46.67M | 18.35M | -5.48M |
| Net Income | 8.16B | 5.88B | 7.13B | 6.54B | 4.68B | 3.87B | 4.69B | 5.07B | 4.01B | 3.10B | 2.34B | 1.12B | 772.66M | 507.13M | 340.04M | 254.31M | 218.81M | 146.61M | 123.46M | 98.49M |
| Net Income Ratio | 19.39% | 15.71% | 21.70% | 22.97% | 18.26% | 19.19% | 22.75% | 26.45% | 23.51% | 21.30% | 19.80% | 12.16% | 11.41% | 10.04% | 8.34% | 7.28% | 7.07% | 5.68% | 5.37% | 4.96% |
| EPS | 64.82 | 45.89 | 54.97 | 50.06 | 35.73 | 29.32 | 35.50 | 38.39 | 31.49 | 23.49 | 17.75 | 8.51 | 5.86 | 3.85 | 2.58 | 1.93 | 1.66 | 1.11 | 0.94 | 0.75 |
| EPS Diluted | 64.77 | 45.89 | 54.96 | 50.06 | 35.73 | 29.31 | 35.50 | 38.39 | 31.49 | 23.47 | 17.71 | 8.49 | 5.85 | 3.85 | 2.58 | 1.93 | 1.66 | 1.11 | 0.94 | 0.75 |
| Weighted Avg Shares Out | 125.92M | 128.12M | 129.66M | 130.62M | 130.89M | 132.00M | 132.00M | 132.01M | 131.99M | 131.91M | 131.81M | 131.75M | 131.72M | 131.72M | 131.72M | 131.72M | 131.72M | 131.72M | 131.72M | 131.72M |
| Weighted Avg Shares Out (Dil) | 126.01M | 128.12M | 129.66M | 130.62M | 130.90M | 132.02M | 132.03M | 132.04M | 132.00M | 132.04M | 132.04M | 132.06M | 132.03M | 131.72M | 131.72M | 131.72M | 131.72M | 131.72M | 131.72M | 131.72M |
Source: https://incomestatements.info
Category: Stock Reports